Literature DB >> 32112169

Surgical management of craniopharyngiomas in adult patients: a systematic review and consensus statement on behalf of the EANS skull base section.

Giulia Cossu1, Emmanuel Jouanneau2, Luigi M Cavallo3, Samer K Elbabaa4, Lorenzo Giammattei1, Daniele Starnoni1, Juan Barges-Coll1, Paolo Cappabianca3, Vladimir Benes5, Mustafa K Baskaya6, Michael Bruneau7, Torstein Meling8, Karl Schaller8, Ari G Chacko9, A Samy Youssef10, Diego Mazzatenta11, Mario Ammirati12, Henry Dufour13, Edward Laws14, Moncef Berhouma2, Roy Thomas Daniel1, Mahmoud Messerer15.   

Abstract

BACKGROUND AND
OBJECTIVE: Craniopharyngiomas are locally aggressive neuroepithelial tumors infiltrating nearby critical neurovascular structures. The majority of published surgical series deal with childhood-onset craniopharyngiomas, while the optimal surgical management for adult-onset tumors remains unclear. The aim of this paper is to summarize the main principles defining the surgical strategy for the management of craniopharyngiomas in adult patients through an extensive systematic literature review in order to formulate a series of recommendations.
MATERIAL AND METHODS: The MEDLINE database was systematically reviewed (January 1970-February 2019) to identify pertinent articles dealing with the surgical management of adult-onset craniopharyngiomas. A summary of literature evidence was proposed after discussion within the EANS skull base section.
RESULTS: The EANS task force formulated 13 recommendations and 4 suggestions. Treatment of these patients should be performed in tertiary referral centers. The endonasal approach is presently recommended for midline craniopharyngiomas because of the improved GTR and superior endocrinological and visual outcomes. The rate of CSF leak has strongly diminished with the use of the multilayer reconstruction technique. Transcranial approaches are recommended for tumors presenting lateral extensions or purely intraventricular. Independent of the technique, a maximal but hypothalamic-sparing resection should be performed to limit the occurrence of postoperative hypothalamic syndromes and metabolic complications. Similar principles should also be applied for tumor recurrences. Radiotherapy or intracystic agents are alternative treatments when no further surgery is possible. A multidisciplinary long-term follow-up is necessary.

Entities:  

Keywords:  Craniopharyngioma; Endoscopy; Pituitary; Skull base; Surgery

Year:  2020        PMID: 32112169     DOI: 10.1007/s00701-020-04265-1

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  16 in total

Review 1.  Modern endoscopic skull base neurosurgery.

Authors:  Rafael Martinez-Perez; Luis C Requena; Ricardo L Carrau; Daniel M Prevedello
Journal:  J Neurooncol       Date:  2021-02-21       Impact factor: 4.130

2.  Endoscopic extended transsphenoidal surgery for newly diagnosed paediatric craniopharyngiomas.

Authors:  Mohsen Javadpour; Michael Amoo; Darach Crimmins; John Caird; Patricia Daly; Jane Pears; Cormac Owens; Michael Capra; Declan Cody
Journal:  Childs Nerv Syst       Date:  2021-03-05       Impact factor: 1.475

Review 3.  Update on management of craniopharyngiomas.

Authors:  Fraser Henderson; Theodore H Schwartz
Journal:  J Neurooncol       Date:  2021-11-22       Impact factor: 4.130

Review 4.  Brachytherapy in paediatric craniopharyngiomas: a systematic review and meta-analysis of recent literature.

Authors:  M Mazzuia Guimarães; D Dante Cardeal; M Jacobsen Teixeira; J Erasmo Dal Col Lucio; F Hada Sanders; R Kei Kuromoto; H Matushita
Journal:  Childs Nerv Syst       Date:  2021-10-07       Impact factor: 1.475

5.  Craniopharyngiomas: Surgery and Radiotherapy.

Authors:  Sergey Gorelyshev; Alexander N Savateev; Nadezhda Mazerkina; Olga Medvedeva; Alexander N Konovalov
Journal:  Adv Tech Stand Neurosurg       Date:  2022

6.  Surgical Outcomes of Endoscopic Endonasal Surgery in 29 Patients with Craniopharyngioma.

Authors:  Arad Iranmehr; Mostafa Esmaeilnia; Khashayar Afshari; Seyed Mousa Sadrehosseini; Azin Tabari; Morteza Faghih Jouibari; Mehdi Zeinalizadeh
Journal:  J Neurol Surg B Skull Base       Date:  2020-06-19

7.  Sex Hormone Receptor Expression in Craniopharyngiomas and Association with Tumor Aggressiveness Characteristics.

Authors:  Antonio Martínez-Ortega; Álvaro Flores-Martinez; Eva Venegas-Moreno; Elena Dios; Diego Del Can; Eloy Rivas; Ariel Kaen; Eugenio Cárdenas Ruiz-Valdepeñas; Elena Fajardo; Florinda Roldán; Natividad González-Rivera; Rosario Oliva; José Ignacio Fernández-Peña; Alfonso Soto-Moreno; David A Cano
Journal:  J Clin Med       Date:  2022-01-05       Impact factor: 4.241

8.  Proton therapy for craniopharyngioma in adults: a protocol for systematic review and meta-analysis.

Authors:  Pengtao Li; Jialing Wang; Aximujiang Axier; Kai Zhou; Jingwei Yun; Huayi Wang; Tingrong Zhang; Shaoshan Li
Journal:  BMJ Open       Date:  2021-06-01       Impact factor: 2.692

9.  The safety and efficacy of endoscopic endonasal approach in the treatment of recurrent craniopharyngioma: A protocol for systematic review and meta-analysis.

Authors:  Pengtao Li; Aximujiang Axier; Shaoshan Li; Kai Zhou; Jingwei Yun; Huayi Wang; Tingrong Zhang
Journal:  Medicine (Baltimore)       Date:  2020-12-04       Impact factor: 1.817

Review 10.  Safety of growth hormone (GH) treatment in GH deficient children and adults treated for cancer and non-malignant intracranial tumors-a review of research and clinical practice.

Authors:  Margaret C S Boguszewski; Adriane A Cardoso-Demartini; Cesar Luiz Boguszewski; Wassim Chemaitilly; Claire E Higham; Gudmundur Johannsson; Kevin C J Yuen
Journal:  Pituitary       Date:  2021-07-25       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.